Skip to content
ABOUT US

Advancing Tomorrow’s Medicines

Our daily motivation is to advance biopharmaceutical drug development to help cure diseases and enhance patients' quality of life—a commitment we've upheld for 30 years and will continue to honor for decades to come. 

Vision & Mission

For one world in which there is treatment for every disease

With our knowledge and unique technologies, we facilitate the development of tomorrow´s medicines today - even for diseases that are not yet curable.
Asset 10

Who We Are and What We Do

Guided by our vision and mission, ProBioGen has developed numerous innovative technologies and biopharmaceutical active ingredients for our clients. 

We are a recognized leader in contract development and manufacturing organizations (CDMOs) and pioneering technology provision. Our expertise spans the spectrum of cell line engineering, process development, and good manufacturing practice (GMP) manufacturing of biopharmaceuticals, catering to discerning clients in the biopharmaceutical sector. We proudly offer a suite of proprietary, tailored technologies designed to elevate the efficiency and precision of biopharmaceutical manufacturing and analysis. Among others these are proven technologies which are used in approved products. 

We also provide process development, GMP manufacturing services, and advanced technologies specifically designed for viral vaccines, as well as innovations in cell and gene therapy (CGT). 

>

Employees

Production Sites

Years of Experience

%

Quality

Global Customer Base

pbg-map-2018
The success of our client's projects is the motivation for our experienced and flexible teams of scientists, engineers, and technicians. We are a reliable and agile partner when developing our clients' products, to the benefit of patients worldwide. In order to meet the increasing demands of our clients, we have expanded our manufacturing capacity with a cutting-edge facility, which allows GMP manufacturing at 1000L scale in single-use bioreactors. With the implementation of an additional 1000L GMP manufacturing line we accommodated our client’s needs for more capacity and flexibility.

Partners & References

The remarkable scientific progress over the last two decades has given rise to the development of new technologies at an unprecedented pace. Our partnerships are collaborative and target specific results, with a strong focus on value for our end customers. 

thermo
Thermo Fisher Scientific

We engineered the Freedom™ CHO-S™ Kit platform, which enables cost-and-time-efficient stable cell line development for research and commercial purposes, in close collaboration with Thermo Fisher Scientific. The kit is available via Thermo Fisher Scientific. 

boehringer-1
Boehringer Ingelheim

Boehringer Ingelheim has a non-exclusive license for ProBioGen's proprietary GlymaxX® ADCC enhancement technology (Antibody-Dependent Cell-Mediated Cytotoxicity) to produce antibodies with enhanced ADCC potency.

thermo
Thermo Fisher Scientific

We engineered the Freedom™ CHO-S™ Kit platform, which enables cost-and-time-efficient stable cell line development for research and commercial purposes, in close collaboration with Thermo Fisher Scientific. The kit is available via Thermo Fisher Scientific.

boehringer-1
Boehringer Ingelheim

Boehringer Ingelheim has a non-exclusive license for ProBioGen’s proprietary GlymaxX® ADCC enhancement technology (Antibody-Dependent Cell-Mediated Cytotoxicity). Under this license, Boehringer Ingelheim applies GlymaxX for third parties from its global contract manufacturing platform as well as to its own development candidates, to produce antibodies with enhanced ADCC potency.

References

Our customer range is extensive; some of our key customers and selected references include: 

Logo-01
Logo-17
Logo-16
Logo-14
Logo-02
Logo-04
Logo-06
Logo-05
Logo-07
Logo-08
Logo-09
Logo-10
Logo-11
Logo-13
Logo-12
Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.